🇺🇸 FDA

Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 34 of 39

  1. XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial

  2. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial

  3. XR-B (SUBLOCADETM)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule completed

    1 trial

  4. Xiang Sha Liu Jun Zi Decoction dry powder

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule completed

    1 trial

  5. Xingnaojing injection

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    1 trial

  6. Xingnaojing injection

    Universal Integrated

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  7. Xingnaojing injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  8. Xinnaoning Capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Stable Angina Pectoris

    approved small molecule active

    1 trial

  9. Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets

    Bayer AG

    metastatic castrate resistant prostate cancer (mCRPC)

    approved small molecule active

    1 trial

  10. Xolair

    United Therapeutics Europe Ltd

    Atopic Eczema

    approved small molecule completed

    1 trial

  11. Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  12. Xolair 75 mg solution for injection in pre-filled syringe

    Pari Pharma GmbH

    Well controlled severe allergic asthma

    approved small molecule active

    1 trial

  13. Xtampza ER (oxycodone)

    COLLEGIUM PHARMACEUTICAL, INC

    Chronic Pain

    approved small molecule terminated

    1 trial

  14. Xtandi - 40 mg soft capsules

    The George Institute

    PROSTATE CANCER

    approved small molecule active

    1 trial

  15. Xuebijing

    Rocket Pharmaceuticals B.V.

    Pulmonary Disease, Chronic Obstructive

    approved small molecule active

    1 trial

  16. Xuebijing Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule completed

    2 trials

  17. Xuesaitong Soft Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    2 trials

  18. Xueshuanxinmaining tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  19. Xyrem (X)

    Jazz Pharmaceuticals Ireland Limited

    Obstructive Sleep Apnea Syndrome

    approved small molecule completed

    1 trial

  20. Yiqitongluo granule

    The First People's Hospital of Lianyungang

    Stroke

    approved small molecule completed

    1 trial

  21. Yuflyma 40 mg solution for injection in pre-filled pen, Hyrimoz 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled pen, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled s

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial

  22. Z-Brace interbody fusion device

    Hospital Authority, Hong Kong

    Cervical Disc Degeneration

    approved other active

    1 trial

  23. ZULRESSO®

    SUPERNUS PHARMACEUTICALS, INC.

    Postpartum Depression

    approved small molecule completed

    1 trial

  24. ZYNRELEF 200Mg-6Mg Extended-Release Solution

    Heron Therapeutics

    Post Operative Pain, Acute

    approved small molecule active

    1 trial

  25. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Waldenström's Macroglobulinemia

    approved small molecule active

    1 trial

  26. Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione

    Verona Pharma Ireland Limited

    Patients with currently remitted depressive disorders.

    approved small molecule active

    1 trial

  27. Zavicefta, Ceftazidime-Avibactam

    Pfizer

    Hospital-Acquired Pneumonia

    approved small molecule completed

    1 trial

  28. Zeposia 0.92 mg hard capsules

    Verona Pharma Ireland Limited

    Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)

    approved small molecule active

    1 trial

  29. Zhenyuan capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stable Coronary Heart Disease

    approved small molecule active

    1 trial

  30. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZ 300 mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  31. Zithromax

    United Therapeutics Europe Ltd

    Asthma

    approved small molecule completed

    1 trial

  32. Zoledronate

    United Therapeutics Europe Ltd

    Hip Fractures

    approved small molecule active

    1 trial

  33. Zoledronic Acid

    Novartis Pharmaceuticals

    Paget's Disease of the Bone

    approved small molecule completed

    1 trial

  34. Zushima plaster with high dose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoarthritis

    approved small molecule completed

    1 trial

  35. [68Ga]FAPI-46

    Disc Medicine

    Non-resolving ARDS

    approved small molecule active

    1 trial

  36. [68Ga]FAPI-46

    Disc Medicine

    Peyronie's Disease

    approved small molecule active

    1 trial

  37. [68Ga]FAPI-46

    Disc Medicine

    post-acute sequelae of COVID-19

    approved small molecule active

    1 trial

  38. a control group

    The First People's Hospital of Lianyungang

    Disorder of Stomach Function and Feeding Problems in Newborn

    approved small molecule completed

    1 trial

  39. adefovir dipivoxil

    GlaxoSmithKline

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial

  40. aflibercept 2.0 mg

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  41. aflibercept 2.0 mg

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule completed

    1 trial

  42. albumin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  43. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease

    approved mab completed

    1 trial

  44. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease (Infantile-Onset)

    approved mab terminated

    1 trial

  45. allopurinol

    United Therapeutics Europe Ltd

    Gout

    approved small molecule completed

    1 trial

  46. alogliptin+pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  47. aripiprazole

    Otsuka Beijing Research Institute

    Bipolar Disorder

    approved small molecule completed

    1 trial

  48. armodafinil

    Teva Pharma GmbH

    Sleep Disorders

    approved small molecule completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.